{
  "docId": "019dd923-5f69-752d-a9b7-cb9ca917cc95",
  "docSlug": "RKx0dsiKeHCYSDIkE7uF",
  "documentTitle": "Cyclica is already using AI to discover new medicines based on psychedelics. Here's the presentation the biotech startup used to raise a fresh $17 million.",
  "authorId": "Pitchdecks",
  "authorName": "Cyclica",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.78,
  "pageNumber": 7,
  "pageCount": 10,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "testimonial",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses social proof to validate the business model.",
  "elementsJson": [
    "headline_text",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b7-cb9ca917cc95/7",
  "deckHref": "/decks/019dd923-5f69-752d-a9b7-cb9ca917cc95",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b7-cb9ca917cc95.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b7-cb9ca917cc95#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "image",
      "text": "Tieös Pharmaceuticals",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0eb66db7-5ada-41ad-b125-b39ed46be71e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.05,
        "y": 0.75
      },
      "kind": "image",
      "text": "University of Toronto",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "124824a9-df59-4624-ae1f-e16b112c9376",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.6,
        "y": 0.45
      },
      "kind": "image",
      "text": "Merck KGaA",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66f63b95-aeb4-4210-ae94-3d75f7b22943",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.08,
        "y": 0.1
      },
      "kind": "paragraph",
      "text": "Our business model has been adopted in the industry, and contributed to the research efforts of early stage biotech, research institutes, and multinational companies globally.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80e7f7fa-ef6f-4cca-8d0c-79d3fd853092",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.38,
        "y": 0.25
      },
      "kind": "quote",
      "text": "The molecules we’ve synthesized have shown good solubility, multitargeted biophysical interaction and have evidenced good safety, efficacy and pharmacokinetics in our in vivo models.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a95e35d-96e6-4c31-964b-76c213d20792",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.55,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "quote",
      "text": "...artificial intelligence applications like Ligand Express® will provide important insights to enhance how we think about target identification to support phenotypic screening and off-target profiling in general...",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22f2f095-0fd2-4559-ab7f-8127959a7500",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.38,
        "y": 0.75
      },
      "kind": "quote",
      "text": "We are extremely pleased to be working with Cyclica...our collaboration represents a unique approach that unites two completely novel and complementary approaches...",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f68241d-59b9-4871-b278-3bdbbf9861fb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "The molecules we’ve synthesized have shown good solubility, multitargeted biophysical interaction and have evidenced good safety, efficacy and pharmacokinetics in our in vivo models. He adds that his team has been blown away by what we are seeing. - Dr. Arun Anand, Founder and CEO, Tieös Pharma",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-a28e-768f-b415-e3f71dcf4eca",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "eb6c35ec-84fc-4eb9-8cc0-fb03256b60f4",
      "evidence": "Use of quotes from industry leaders and academic experts to build credibility.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 9,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "6deaf774-516a-46da-9cd4-8fce54352f51",
      "evidence": "The document implies that traditional AI in drug discovery companies are limited, and Cyclica's platform offers a more comprehensive solution.",
      "position": 0,
      "objective": "What is the cost of not adopting a more holistic approach to drug discovery?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}